Review



12-gene risk score endopredict  (Sividon Diagnostics GmbH)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Sividon Diagnostics GmbH 12-gene risk score endopredict
    Summary of Original Recommendations for Question 1 With Focused Updated Recommendations
    12 Gene Risk Score Endopredict, supplied by Sividon Diagnostics GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/endopredict%C2%AE+risk+score/12+gene+risk+score+endopredict/pmc05846188-5-18-22
    Average 90 stars, based on 1 article reviews
    12-gene risk score endopredict - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update"

    Article Title: Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

    Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

    doi: 10.1200/JCO.2017.74.0472

    Summary of Original Recommendations for Question 1 With Focused Updated Recommendations
    Figure Legend Snippet: Summary of Original Recommendations for Question 1 With Focused Updated Recommendations

    Techniques Used: Adjuvant, Labeling, Immunohistochemistry, Gene Expression

    Related Articles

    other:

    Article Title: Intrinsic Subtypes of Primary Breast Cancer--Gene Expression Analysis.
    Article Snippet: The EndoPredict® (EP; Sividon Diagnostics GmbH, Cologne, Germany) risk score was developed using a supervised top-down approach focusing on genes correlated with distant metastasis.



    Similar Products

    12-gene risk score endopredict  (Myriad Genetics)
    90
    Myriad Genetics 12-gene risk score endopredict
    12 Gene Risk Score Endopredict, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/endopredict%C2%AE+risk+score/12+gene+risk+score+endopredict/pmc11880448-96-27-31
    Average 90 stars, based on 1 article reviews
    12-gene risk score endopredict - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    12-gene risk score endopredict  (Sividon Diagnostics GmbH)
    90
    Sividon Diagnostics GmbH 12-gene risk score endopredict
    Summary of Original Recommendations for Question 1 With Focused Updated Recommendations
    12 Gene Risk Score Endopredict, supplied by Sividon Diagnostics GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/endopredict%C2%AE+risk+score/12+gene+risk+score+endopredict/pmc05846188-5-18-22
    Average 90 stars, based on 1 article reviews
    12-gene risk score endopredict - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    endopredict® risk score  (Sividon Diagnostics GmbH)
    90
    Sividon Diagnostics GmbH endopredict® risk score
    Summary of Original Recommendations for Question 1 With Focused Updated Recommendations
    Endopredict® Risk Score, supplied by Sividon Diagnostics GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/endopredict%C2%AE+risk+score/endopredict++risk+score/pm27031354-138-1-3
    Average 90 stars, based on 1 article reviews
    endopredict® risk score - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Summary of Original Recommendations for Question 1 With Focused Updated Recommendations

    Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

    Article Title: Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

    doi: 10.1200/JCO.2017.74.0472

    Figure Lengend Snippet: Summary of Original Recommendations for Question 1 With Focused Updated Recommendations

    Article Snippet: 1.6 , If a patient has HER2-positive breast cancer or triple-negative breast cancer, the clinician should not use 12-gene risk score (EndoPredict; Sividon Diagnostics) to guide decisions for adjuvant systemic therapy. , Type: informal consensus Evidence quality: insufficient Strength of recommendation: strong.

    Techniques: Adjuvant, Labeling, Immunohistochemistry, Gene Expression